ReviewJournal of cardiovascular translational research2020
Myocarditis in the Athlete: Arrhythmogenic Substrates, Clinical Manifestations, Management, and Eligibility Decisions.
Review in Journal of cardiovascular translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 19 citations in OpenAlex.
- The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- Return-to-Play Post-Myocarditis for Athletes: To Play or Not to Play?Diagnostics (Basel, Switzerland) · 2024Review
- Myocarditis and sports in the young: data from a nationwide registry on myocarditis-"MYKKE-Sport".Frontiers in sports and active living · 2023Article
- Sports, Myocarditis and COVID-19: Diagnostics, Prevention and Return-to-play Strategies.International journal of sports medicine · 2022Review
- May Strenuous Endurance Sports Activity Damage the Cardiovascular System of Healthy Athletes? A Narrative Review.Journal of cardiovascular development and disease · 2022Review
- Arrhythmogenic left ventricular cardiomyopathy.Heart (British Cardiac Society) · 2022Article
- Viral Myocarditis: Classification, Diagnosis, and Clinical Implications.Frontiers in cardiovascular medicine · 2022Review
- Potential role of an athlete-focused echocardiogram in sports eligibility.World journal of cardiology · 2021Review
- Wearable cardioverter-defibrillator: friend or foe in suspected myocarditis?ESC heart failure · 2021Observational
- The Challenging and Amazing Field of Sports Cardiology.Journal of cardiovascular translational research · 2020Article
- Managing the combined consequences of COVID-19 infection and lock-down policies on athletes: narrative review and guidelines proposal for a safe return to sport.BMJ open sport & exercise medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocarditis is as an important cause of sudden cardiac death (SCD) among athletes. The incidence of SCD ascribed to myocarditis did not change after the introduction of pre-participation screening in Italy, due to the transient nature of the disease and problems in the differential diagnosis with the athlete's heart. The arrhythmic burden and the underlying mechanisms differ between the acute and chronic setting, depending on the relative impact of acute inflammation versus post-inflammatory myocardial fibrosis. In the acute phase, ventricular arrhythmias vary from isolated ventricular ectopic beats to complex tachycardias that can lead to SCD. Atrioventricular blocks are typical of specific forms of myocarditis, and supraventricular arrhythmias may be observed in case of atrial inflammation. Athletes with acute myocarditis should be temporarily restricted from physical exercise, until complete recovery. However, ventricular tachycardia may also occur in the chronic phase in the context of post-inflammatory myocardial scar.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.